Sage Therapeutics Price Target Cut to $8.00/Share From $9.00 by Oppenheimer

sage therapeutics目標股價從9.00美元下調至8.00美元，由Oppenheimer執行

道瓊斯 · 10/31 00:13 · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.